These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Cardiovascular morbidity and mortality in renal diseases]. Kücükköylü S, Rump LC. Dtsch Med Wochenschr; 2013 Apr 17; 138(14):721-4. PubMed ID: 23533038 [No Abstract] [Full Text] [Related]
9. Effect of anaemia on mortality, cardiovascular hospitalizations and end-stage renal disease among patients with chronic kidney disease. Thorp ML, Johnson ES, Yang X, Petrik AF, Platt R, Smith DH. Nephrology (Carlton); 2009 Apr 17; 14(2):240-6. PubMed ID: 19207866 [Abstract] [Full Text] [Related]
11. Uric acid, cardiovascular mortality, and long-term outcomes in CKD. Turgut F, Kasapoğlu B, Kanbay M. Am J Kidney Dis; 2009 Sep 17; 54(3):582; author reply 582-3. PubMed ID: 19700064 [No Abstract] [Full Text] [Related]
12. Relationship between chronic kidney disease prevalence and end-stage renal disease risk. Hallan SI, Vikse BE. Curr Opin Nephrol Hypertens; 2008 May 17; 17(3):286-91. PubMed ID: 18408480 [Abstract] [Full Text] [Related]
13. Influence of interleukin-6 G-174C gene polymorphism on coronary artery disease, cardiovascular complications and mortality in dialysis patients. Aker S, Bantis C, Reis P, Kuhr N, Schwandt C, Grabensee B, Heering P, Ivens K. Nephrol Dial Transplant; 2009 Sep 17; 24(9):2847-51. PubMed ID: 19349293 [Abstract] [Full Text] [Related]
14. Letter by Undas and Jakubowski regarding article, "Relationship between homocysteine and mortality in chronic kidney disease". Undas A, Jakubowski H. Circulation; 2006 Oct 17; 114(16):e547; author reply e548. PubMed ID: 17043173 [No Abstract] [Full Text] [Related]
15. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study. Panichi V, Rizza GM, Paoletti S, Bigazzi R, Aloisi M, Barsotti G, Rindi P, Donati G, Antonelli A, Panicucci E, Tripepi G, Tetta C, Palla R, RISCAVID Study Group. Nephrol Dial Transplant; 2008 Jul 17; 23(7):2337-43. PubMed ID: 18305316 [Abstract] [Full Text] [Related]
16. Parathyroidectomy reduces cardiovascular events and mortality in renal hyperparathyroidism. Costa-Hong V, Jorgetti V, Gowdak LH, Moyses RM, Krieger EM, De Lima JJ. Surgery; 2007 Nov 17; 142(5):699-703. PubMed ID: 17981190 [Abstract] [Full Text] [Related]
17. Assessing cardiac risk in the renal patient: do the general rules apply? Soman P, Jain D. Nucl Med Commun; 2008 Jun 17; 29(6):507-10. PubMed ID: 18458596 [No Abstract] [Full Text] [Related]
18. Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients. de Mutsert R, Grootendorst DC, Axelsson J, Boeschoten EW, Krediet RT, Dekker FW, NECOSAD Study Group. Nephrol Dial Transplant; 2008 Sep 17; 23(9):2957-64. PubMed ID: 18400817 [Abstract] [Full Text] [Related]
19. C- Reactive protein, cardiac troponin T and low albumin are predictors of mortality in hemodialysis patients. Bagheri N, Taziki O, Falaknazi K. Saudi J Kidney Dis Transpl; 2009 Sep 17; 20(5):789-93. PubMed ID: 19736474 [Abstract] [Full Text] [Related]
20. Elevated cardiac troponin T predicts cardiovascular events in asymptomatic continuous ambulatory peritoneal dialysis patients without a history of cardiovascular disease. Han SH, Choi HY, Kim DK, Moon SJ, Lee JE, Yoo TH, Kim BS, Kang SW, Choi KH, Lee HY, Han DS. Am J Nephrol; 2009 Sep 17; 29(2):129-35. PubMed ID: 18719346 [Abstract] [Full Text] [Related] Page: [Next] [New Search]